Dichlorphenamide

FDA Drug Profile — ORMALVI, Dichlorphenamide, Keveyis

Dichlorphenamide is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including ORMALVI, Dichlorphenamide, Keveyis. Available dosage forms: tablet, powder.

Drug Details

Generic Name
Dichlorphenamide
Brand Names
ORMALVI, Dichlorphenamide, Keveyis
Application Number
ANDA215924
Sponsor
Cycle Pharmaceuticals Ltd.
NDC Codes
7
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
DICHLORPHENAMIDE

Indications and Usage

1 INDICATIONS AND USAGE KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. KEVEYIS is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )